galactosamine has been researched along with 16,16-dimethylprostaglandin e2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, S; Hirata, K; Masaki, N; Mochida, S; Nagoshi, S; Ogata, I; Ohta, Y; Shirataki, H; Tomiya, T; Yamada, S | 1 |
| Bogdał, J; Kirchmayer, S; Klimczyk, B; Mach, T; Stachura, J; Szczudrawa, J; Tarnawski, A | 1 |
2 other study(ies) available for galactosamine and 16,16-dimethylprostaglandin e2
| Article | Year |
|---|---|
Hepatocyte membrane stabilization by prostaglandins E1 and E2: favorable effects on rat liver injury.
Topics: 16,16-Dimethylprostaglandin E2; Alprostadil; Animals; Bucladesine; Carbon Tetrachloride; Cell Membrane; Cells, Cultured; Galactosamine; Lipid Peroxidation; Liver Cirrhosis, Experimental; Male; Malondialdehyde; Membrane Fluidity; Rats; Rats, Inbred F344; Rats, Inbred Strains | 1992 |
Cytoprotective effect of 16, 16' dimethyl prostaglandin E2 and some drugs on an acute galactosamine induced liver damage in rat.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Chemical and Drug Induced Liver Injury; Choline; Drug Combinations; Galactosamine; Liver; Liver Cirrhosis; Male; Orotic Acid; Premedication; Prostaglandins E, Synthetic; Rats | 1980 |